leadership
confidence high
sentiment positive
materiality 0.50
PetMed Express appoints Peter Batushansky to Board; Dr. Fulgoni to retire at 2025 annual meeting
PETMED EXPRESS INC
- Peter Batushansky, former CEO of Allivet and current partner at L2 Capital Partners, joins board effective April 9, 2025.
- Batushansky will serve on Audit Committee and Corporate Governance and Nominating Committee; board expands from 6 to 7 members.
- Dr. Gian Fulgoni, longtime board member and former Chairman, will retire when his term expires at the 2025 annual shareholders' meeting.
- This is the third independent director added since 2024; company highlights ongoing board refreshment and transformation strategy.